Zeta (ZETA) Q4 2025 Earnings Transcript

Zeta Global delivered a strong Q4 with revenue of $395 million, up 28% ex-acquisitions and political candidate revenue, adjusted EBITDA of $95.1 million (+35%), and free cash flow of $55.8 million (+76%), while turning GAAP net income positive at $6.5 million. Management raised 2026 revenue guidance by $25 million to $1.755 billion and lifted 2026 EBITDA and free cash flow targets, while also signaling minimal Athena contribution in the guide and at least $190 million of Marigold revenue. The call highlighted record 120% net revenue retention, accelerated multi-use case adoption, and continued aggressive buybacks, reinforcing a positive fundamental and AI-driven growth narrative.

Analysis

The core takeaway is not simply that Zeta is growing faster; it is that the revenue mix is becoming less fragile. When a platform shifts toward larger customers, higher multi-product penetration, and stronger retention, the second-order effect is that incremental growth becomes easier to self-fund: sales efficiency improves, support burden is spread over larger accounts, and buybacks start to matter more because dilution is finally being contained. That combination usually precedes multiple expansion because the market stops underwriting the business as a “story stock” and starts underwriting it as a compounding cash generator.

The most important competitive signal is that the company is reframing AI as a workflow control layer, not a standalone feature. That matters because generic model providers can help with content generation, but they do not own activation, identity, or closed-loop measurement; if Zeta is right, AI should increase switching costs rather than compress them. The risk for peers is that enterprise buyers may consolidate spend into fewer vendors once the ROI math becomes easier to prove, which is especially negative for point-solution incumbents that rely on fragmented budgets and weak attribution.

The contrarian angle is that the market may underappreciate how much of the near-term upside is already embedded in guidance math versus how much is still optionality. The base case looks derisked, but the real catalyst window is the next 2-3 quarters: Athena GA, Marigold cross-sell, and evidence that multi-use-case adoption keeps rising without sacrificing margin. The main failure mode is execution friction — if Athena adoption is slower than management implies, or if customer expansion is concentrated in a few verticals and stalls, the valuation can re-rate quickly because a lot of the bull case depends on the durability of the flywheel, not just the quarter itself.

Key Decisions for Investors

• Go long ZETA on any post-earnings consolidation; use a 2-3 month horizon and size for 15-20% upside if the market re-rates the business on FCF conversion and ATHENA optionality.
• Pair trade: long ZETA / short TTD over the next 1-2 quarters. The thesis is that Zeta’s deterministic data + activation stack is gaining share from platform-adjacent spend, while TTD is more exposed to budget scrutiny and a less defensible closed-loop ROI story.
• Buy ZETA call spreads into Athena general availability: e.g., 3-6 month maturities with strikes around 10-15% above spot to capture a catalyst-driven move while limiting downside if adoption is slower than expected.
• If running a basket, rotate exposure from CRM/ADBE/ORCL into ZETA on any weakness. This is a cleaner way to express that enterprise buyers are consolidating into measurable outcome vendors rather than broad software suites.
• Set a tactical stop if next-quarter commentary shows Athena contributing no measurable lift to expansion metrics; that would invalidate the near-term upside case and likely compress the multiple for 1-2 quarters.